Top

Published in:

01-08-2018 | Case Presentation Corner

Integrating imaging modalities for diagnosing cardiac amyloidosis

Authors: M. Ahluwalia, MD, A. Reyentovich, MD, R. Donnino, MD, L. M. Phillips, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2018

Excerpt

A 76-year-old male with a history of partial small bowel obstructions and biliary stricture presented with dyspnea on exertion. He reported he was in a good state of health until 3 years ago when he noticed shortness of breath when climbing a flight of stairs. His shortness of breath progressively worsened 6 months prior to presentation and was associated with non-radiating chest tightness. He denied paroxysmal nocturnal dyspnea, orthopnea, lightheadedness/dizziness, palpitations, or syncope. …

Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–71.CrossRefPubMed

Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451–66.CrossRefPubMed

Ruberg FL, Nezafat R. Cardiovascular magnetic resonance visualization of cardiac amyloid infiltration: Challenges and opportunities. Circulation. 2015;132:1525–7.CrossRefPubMedPubMedCentral

Falk R. Bullseye strain pattern with normal ejection fraction-a clue to cardiac amyloidosis. Eur Heart J. 2007;28:608–9.

Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570–9.CrossRefPubMedPubMedCentral

Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T, Rosmini S, Quarta CC, Whelan CJ, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70:466–77.CrossRefPubMed

Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation. 2017;135:1357–77.CrossRefPubMedPubMedCentral

Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–12.CrossRefPubMed

https://www.asnc.org/Files/Practice%20Resources/Practice%20Points/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf. Accessed 20 May 2018.

10.

Law WP, Wang WY, Moore PT, Mollee PN, Ng AC. Cardiac amyloid imaging with ¹⁸F-florbetaben PET: A pilot study. J Nucl Med. 2016;57:1733–9.CrossRefPubMed

11.

Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR, Di Carli MF, et al. Imaging cardiac amyloidosis: A pilot study using ¹⁸F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652–62.CrossRefPubMed

12.

Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, et al. ¹⁸F–Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: Autoradiography study. Circ Cardiovasc Imaging. 2015. https://doi.org/10.1161/CIRCIMAGING.114.002954e002954.CrossRefPubMedPubMedCentral

Title: Integrating imaging modalities for diagnosing cardiac amyloidosis
Authors: M. Ahluwalia, MD
A. Reyentovich, MD
R. Donnino, MD
L. M. Phillips, MD
Publication date: 01-08-2018
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 4/2018
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-018-1342-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Integrating imaging modalities for diagnosing cardiac amyloidosis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2018

CME instructions: Radiopharmaceutical tracers for cardiac imaging

Para-atrial non-acute mediastinal hematoma after left atrial maze procedure mimicking tumor in a patient with treated melanoma

An incidental finding on myocardial perfusion imaging with a major impact in altering clinical management

Isolated cardiac sarcoidosis: A focused review of an under-recognized entity

Triage of patients for attenuation-corrected stress-first Tc-99m SPECT MPI using a simplified clinical pre-test scoring model

A quick glance at selected topics in this issue

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page